Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Danger

Hazard statements

H225Highly Flammable liquid and vapour

H370Causes damage to organs

Precautionary statements

P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.

P240Ground/bond container and receiving equipment.

P241Use explosion-proof electrical/ventilating/lighting/…/equipment.

P242Use only non-sparking tools.

P243Take precautionary measures against static discharge.

P260Do not breathe dust/fume/gas/mist/vapours/spray.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P271Use only outdoors or in a well-ventilated area.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P310IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.

P303+P361+P353IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.

P304+P340IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.

P307+P311IF exposed: call a POISON CENTER or doctor/physician.

P312Call a POISON CENTER or doctor/physician if you feel unwell.

P321Specific treatment (see … on this label).

P330Rinse mouth.

P370+P378In case of fire: Use … for extinction.

P403+P233Store in a well-ventilated place. Keep container tightly closed.

P403+P235Store in a well-ventilated place. Keep cool.

P405Store locked up.

P501Dispose of contents/container to..…

9-Tetrahydrocannabivarol-d5 Chemical Properties,Usage,Production

Description

Tetrahydrocannabivarin-d₅ (CRM) is intended for use as an internal standard for the quantification of tetrahydrocannabivarin by GC- or LC-MS. Tetrahydrocannabivarin is categorized as a phytocannabinoid.¹ Tetrahydrocannabivarin is regulated as a Schedule I compound in the United States. Tetrahydrocannabivarin-d₅ (CRM) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.

References

1. Pertwee, R.G. The diverse CB₁ and CB₂ receptor pharmacology of three plant cannabinoids: Δ⁹-Tetrahydrocannabinol, cannabidiol and Δ⁹-tetrahydrocannabivarin Br. J. Pharmacol. 153(2),199-215(2008).